NCT05897086
Polyethylene-glycol Assisted Nerve Repair in Phalloplasty
Enrolling by Invitation
PHASE2Ages 18+InterventionalTreatmentVanderbilt University Medical CenterInvestigator-initiated
~30 participants
Updated 2025-10-20 on ClinicalTrials.gov
What's tested:Polyethylene Glycol 3350
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Medical Research Council Classification (MRCC)
Measured over 15 months
Conditions
Where it's being run
1 sites across 1 statesTennessee1
Study leadership
- Wesley Thayer, MD · PRINCIPAL_INVESTIGATOR · Vanderbilt University Medical Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
over the age of 18
preoperative diagnosis of gender dysphoria and present for planned radial forearm free flap phalloplasty
willing to comply with all aspects of treatment as well as the study evaluation schedule
Exclusion
a known allergy to the study drug
a hematocrit of 54% or higher
a history of venous thromboembolism (VTE), peripheral phlebitis, stroke, or myocardial infarction within the last 6 months.
What this trial measures
- Medical Research Council Classification (MRCC)15 months
measures sensory recovery